(Q48620261)

13 February 2018

title

Risk factors for neuroleptic-induced movement disorders. (English)

1 reference

13 February 2018

author name string

Sandyk R

1

1 reference

13 February 2018

Kay SR

2

1 reference

13 February 2018

Awerbuch GI

3

1 reference

13 February 2018

Iacono RP

4

1 reference

13 February 2018

publication date

1 December 1991

1 reference

13 February 2018

International Journal of Neuroscience

published in

1 reference

13 February 2018

volume

61

1 reference

13 February 2018

issue

3-4

1 reference

13 February 2018

page(s)

149-188

1 reference

13 February 2018

A comparison of purposeless movements in psychiatric patients treated with antipsychotic drugs, and normal individuals

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

The striatonigral degenerations. Putaminal pigments and nosology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Effect of cholinergic and anticholinergic agents on tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Pathology, phenomenology and the dopamine hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Regional specialization of motor functions in the rat striatum: implications for the treatment of parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Parkinson's disease with depression: a possible subgroup of idiopathic parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

A rating scale for tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Memory impairment in schizophrenic patients with tardive dyskinesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Prevalence of tardive dyskinesia in an outpatient population.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

The heterogeneity of Parkinson's disease: clinical and prognostic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Effects of pinealectomy on regional brain serotonin metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Melatonin and Abnormal Movements Induced by L-Dopa in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Melatonin is a potent modulator of dopamine release in the retina.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Reduced nocturnal melatonin secretion in chronic schizophrenia: relationship to body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Smoking and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Posttraumatic movement disorders: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Melatonin receptors in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Melatonin increases in vivo GABA accumulation in rat hypothalamus, cerebellum, cerebral cortex and pineal gland

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Attenuation of reserpine-induced catalepsy by melatonin and the role of the opioid system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Computed tomography (CT) findings in schizophrenia: Speculation on the meaning of it all

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Increase in monoamine concentration in rat brain following melatonin administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Nicotine exposure and tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

The association of tardive dyskinesia and pseudoparkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Endocrine Function and Glucose Metabolism in Patients with Parkinson's Disease and their Alteration byl-Dopa1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Serotonergic function in diabetic rats: psychotherapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Hypokinesia produced by anterolateral hypothalamic 6-hydroxydopamine lesions and its reversal by some antiparkinson drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Serotonergic mechanisms in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Melatonin: Effects on brain and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Postural Asymmetry and Movement Disorder After Unilateral Microinjection of Adrenocorticotropin 1-24 in Rat Brainstem

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Akathisia in idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Dopamine receptor binding is increased in diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Alloxan-induced diabetes and the pineal gland: differential effects on the levels of pineal N-acetylserotonin, pineal melatonin, and serum melatonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Pro-opiomelanocortin peptides in the human hypothalamus: comparative study between normal subjects and Parkinson patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Increased frequency of diabetes mellitus in patients with Huntington's chorea

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Influence of the insulin sensitive central nervous system glucoregulator receptor on hepatic glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Parkinsonism and basal ganglia infarcts.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

The hypothalamus in parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

A controlled study of dementia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Drug-induced parkinsonism in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Psychiatric aspects of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

The pharmacology of tardive dyskinesias

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Regional acetylcholine metabolism in brain during acute hypoglycemia and recovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Persistent tardive dyskinesia and neuroleptic effects on glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Glucose suppresses basal firing and haloperidol-induced increases in the firing rate of central dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Comparative Doses and Costs of Antipsychotic Medication

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Tardive Dyskinesia and Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

The Investigation of Homovanillic Acid in the Human Brain and its Correlation to Senile Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Lateral ventricular size and drug-induced Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Assessment of drugs in schizophrenia. Discussion on assessment of drug- induced extrapyramidal reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Assessment of drugs in schizophrenia. Asessment of drug-induced extrapyramidal reactions and of drugs given for their control

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Extrapyramidal signs in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Clinical and pathological aspects of parkinsonism in Alzheimer's disease. A role for extranigral factors?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Relationship of motor symptoms to intellectual deficits in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

The extrapyramidal disorder of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

The relationship of the reticular system to the primary pathoetiology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Reaction time and vigilance in Parkinson's disease. Possible role of altered norepinephrine metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Alzheimer's disease and senile dementia of Alzheimer type. A comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Neuroleptic-induced akathisia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Clinical characteristics of akathisia. A systematic investigation of acute psychiatric inpatient admissions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Suicide attempts associated with akathisia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

The clinical phenomenon of akathisia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Neuroleptics. Violence as a manifestation of akathisia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Tardive dyskinesia in psychiatric outpatients: a study of prevalence and association with demographic, clinical, and drug history variables.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Akathisia following traumatic brain injury: treatment with bromocriptine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

The many faces of Akathisia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Akathisia with haloperidol and thiothixene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Drug treatment in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Acute dystonia induced by neuroleptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Primitive (developmental) reflexes and diffuse cerebral dysfunction in schizophrenia and bipolar affective disorder: overrepresentation in patients with tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Calcification in the human choroid plexus, meningiomas and pineal gland

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

The active transport of 5-hydroxyindol-3-ylacetic acid and 3-methoxy-4-hydroxyphenylacetic acid from a recirculatory perfusion system of the cerebral ventricles of the unanaesthetized dog

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Iron pigment in the brain of a man with tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Pharmacological characterization of tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Topographic subtypes of tardive dyskinesia in schizophrenic patients aged less than 60 years: relationship to demographic, clinical, treatment, and neuropsychological variables

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Neuropathological findings in three cases of persistent dyskinesia following phenothiazine medication

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Behavioral aspects of serotonin-dopamine interaction in the monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Autonomic Nerves in the Mammalian Choroid Plexus and Their Influence on the Formation of Cerebrospinal Fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Comparison of calcification of pineal, habenular commissure and choroid plexus on plain films and computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Does the choroid plexus really protect the brain from lead?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

The pathophysiology of enlarged ventricles in normal pressure communicating hydrocephalus and schizophrenia: a possible therapeutic role for melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Raphe origin of serotonin-containing neurons within choroid plexus of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Covert Transport Dysfunction in the Choroid Plexus as a Possible Cause of Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Pineal gland calcification and tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Changes in Prevalence, Severity, and Recovery in Tardive Dyskinesia With Age

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

The Histology and Pathology of the Human Pineal Gland

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Human aggression and the role of central serotonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

An unusual cluster of tardive dyskinesia in schizophrenia: association with cognitive dysfunction and negative symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

Differential diagnosis of tardive dyskinesia: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207459108990737

10.3109/00207459108990737

21 January 2018

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018